CAMG
CWA Asset Management Group’s Akebia Therapeutics AKBA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $207K | Buy |
57,000
+8,000
| +16% | +$29.1K | 0.01% | 619 |
|
|
2025
Q1 | $94.1K | Hold |
49,000
| – | – | ﹤0.01% | 589 |
|
|
2024
Q4 | $93.1K | Hold |
49,000
| – | – | ﹤0.01% | 552 |
|
|
2024
Q3 | $64.7K | Buy |
+49,000
| New | +$64.7K | ﹤0.01% | 562 |
|
|
2024
Q1 | $89.7K | Hold |
49,000
| – | – | 0.01% | 524 |
|
|
2023
Q4 | $60.8K | Hold |
49,000
| – | – | ﹤0.01% | 412 |
|
|
2023
Q3 | $55.9K | Hold |
49,000
| – | – | ﹤0.01% | 352 |
|
|
2023
Q2 | $44.8K | Buy |
49,000
+20,000
| +69% | +$18.3K | ﹤0.01% | 354 |
|
|
2023
Q1 | $16.3K | Hold |
29,000
| – | – | ﹤0.01% | 320 |
|
|
2022
Q4 | $16.7K | Hold |
29,000
| – | – | ﹤0.01% | 317 |
|
|
2022
Q3 | $9K | Hold |
29,000
| – | – | ﹤0.01% | 301 |
|
|
2022
Q2 | $10K | Buy |
+29,000
| New | +$10K | ﹤0.01% | 300 |
|